These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15268838)

  • 21. Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma.
    Picton SV; Keeble J; Holden V; Errington J; Boddy AV; Veal GJ
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):749-52. PubMed ID: 18607591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma: evidence for stage-based chemotherapy.
    Chung CY; Medina CA; Aziz HA; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):63-75. PubMed ID: 25436494
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues].
    Wu JH; Xu P; Yi MY; Wang F; Wang XL; Huang Q
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):419-22. PubMed ID: 15938806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene.
    Makkonen KM; Malinen M; Ropponen A; Väisänen S; Carlberg C
    J Mol Biol; 2009 Oct; 393(2):261-71. PubMed ID: 19683536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase of melanogenesis by retinoic acid: an ultrastructural and morphometric study.
    Fernandes SS; Arcuri R; Morgado-Díaz JA; Benchimol M
    Tissue Cell; 2004 Apr; 36(2):95-105. PubMed ID: 15041411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for retinoblastoma.
    Chan HS; Gallie BL; Munier FL; Beck Popovic M
    Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the best treatment for retinoblastoma?
    Harbour JW
    Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
    [No Abstract]   [Full Text] [Related]  

  • 30. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
    Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p27 and MAPK proteins involved in all-trans retinoic acid-induced apoptosis and cell cycle arrest in matched primary and metastatic melanoma cells.
    Zhang H; Rosdahl I
    Int J Oncol; 2004 Nov; 25(5):1241-8. PubMed ID: 15492811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma.
    Krishnakumar S; Mohan A; Kandalam M; Ramkumar HL; Venkatesan N; Das RR
    Pediatr Blood Cancer; 2008 Feb; 50(2):402-6. PubMed ID: 17091485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological features and P-glycoprotein expression in retinoblastoma.
    Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of all-trans-retinoic on human gastric cancer cells BGC-823.
    Zhang JP; Chen XY; Li JS
    J Dig Dis; 2007 Feb; 8(1):29-34. PubMed ID: 17261132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of all trans-retinoic acid on the secretion of IV collagenase.
    Li B; Tian B
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):588-90. PubMed ID: 15567751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ; Zheng J
    Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A review of cell kinetics of brain tumors with use of flow cytometry].
    Kawamoto K
    No Shinkei Geka; 1995 Dec; 23(12):1059-68. PubMed ID: 8927212
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
    Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
    Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis.
    Ekberg J; Brunhoff C; Järås M; Fan X; Landberg G; Persson JL
    Int J Biochem Cell Biol; 2006; 38(8):1330-9. PubMed ID: 16517207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.